相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cell-free circulating tumor DNA profiling in cancer management
Dhruvajyoti Roy et al.
TRENDS IN MOLECULAR MEDICINE (2021)
DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients
Lukas Vrba et al.
EPIGENETICS (2020)
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Cell-Free DNA in Stage I-IV Non-Small Cell Lung Cancer
John Jiang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Clinical implications of intratumor heterogeneity: challenges and opportunities
Santiago Ramon y Cajal et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
Huiyan Luo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden
Cheyennedra C. Bieg-Bourne et al.
MOLECULAR ONCOLOGY (2020)
Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA
Kiyoshi Misawa et al.
ONCOGENE (2020)
Consecutive seeding and transfer of genetic diversity in metastasis
Alexander Heyde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
1411PMethylation analysis of MLH1 using droplet digital PCR and methylation sensitive restriction enzyme
C De Rop et al.
ANNALS OF ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
Stephen R. Fairclough et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases
Willemijne A. M. E. Schrijver et al.
CANCER RESEARCH (2018)
Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients
Claudia Vollbrecht et al.
Oncotarget (2018)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. Planchard et al.
ANNALS OF ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Jingying Nong et al.
NATURE COMMUNICATIONS (2018)
555PCorrelation between ctDNA methylation and CEA in colorectal cancer
W-W Tang et al.
ANNALS OF ONCOLOGY (2018)
Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis
Jagdeep Singh Bhangu et al.
ANNALS OF SURGERY (2018)
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer
Klara M. Giessler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
Progress and prospects of early detection in lung cancer
Sean Blandin Knight et al.
OPEN BIOLOGY (2017)
Genomics alterations of metastatic and primary tissues across 15 cancer types
Gang Liu et al.
SCIENTIFIC REPORTS (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Novel ALK inhibitors in clinical use and development
Chaitanya Iragavarapu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Gefitinib Treatment in EGFR Mutated Caucasian NSCLC Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
Jean-Yves Douillard et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed?
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
SnapShot: Lung Cancer Models
Anna F. Farago et al.
CELL (2012)
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)
Masahiro Fukuoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Improved quantification of DNA methylation using methylation-sensitive restriction enzymes and real-time PCR
Ko Hashimoto et al.
EPIGENETICS (2007)
ROCR: visualizing classifier performance in R
T Sing et al.
BIOINFORMATICS (2005)
Erlotinib in lung cancer - Molecular and clinical predictors of outcome
MS Tsao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
